Orpea SA (ORPEF)
USD 14.22
(0.0%)
USD 14.22
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.63 Billion USD | -56.55% |
| 2022 | 10.65 Billion USD | 2.38% |
| 2021 | 10.41 Billion USD | 8.97% |
| 2020 | 9.55 Billion USD | 28.75% |
| 2019 | 7.42 Billion USD | 32.57% |
| 2018 | 5.59 Billion USD | 14.86% |
| 2017 | 4.87 Billion USD | 9.5% |
| 2016 | 4.45 Billion USD | 43.18% |
| 2015 | 3.1 Billion USD | 12.32% |
| 2014 | 2.76 Billion USD | 43.8% |
| 2013 | 1.92 Billion USD | -0.72% |
| 2012 | 1.93 Billion USD | 3.71% |
| 2011 | 1.86 Billion USD | -1.68% |
| 2010 | 1.9 Billion USD | 19.59% |
| 2009 | 1.58 Billion USD | 19.01% |
| 2008 | 1.33 Billion USD | 28.44% |
| 2007 | 1.04 Billion USD | 101.88% |
| 2006 | 515.23 Million USD | 110.46% |
| 2005 | 244.81 Million USD | -10.05% |
| 2004 | 272.16 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 6 Billion USD | -7.02% |
| 2023 Q1 | 13.62 Billion EUR | 1.77% |
| 2023 FY | 9.16 Billion EUR | -31.55% |
| 2023 Q3 | 9.16 Billion EUR | -32.73% |
| 2023 Q2 | 11.26 Billion USD | 5.73% |
| 2023 Q4 | 6.45 Billion USD | -42.74% |
| 2022 Q2 | 10.27 Billion USD | -1.33% |
| 2022 FY | 13.38 Billion EUR | 10.35% |
| 2022 Q4 | 10.65 Billion USD | 3.77% |
| 2022 Q1 | 12.71 Billion EUR | 4.83% |
| 2022 Q3 | 13.38 Billion EUR | 2.69% |
| 2021 Q2 | 10.12 Billion USD | 6.02% |
| 2021 Q4 | 10.41 Billion USD | 2.78% |
| 2021 Q3 | 12.24 Billion EUR | 8.52% |
| 2021 FY | 12.12 Billion EUR | 15.18% |
| 2021 Q1 | 11.05 Billion EUR | 4.96% |
| 2020 Q4 | 9.55 Billion USD | 19.79% |
| 2020 FY | 10.52 Billion EUR | 18.66% |
| 2020 Q1 | 9.39 Billion EUR | 5.89% |
| 2020 Q2 | 7.97 Billion USD | 7.48% |
| 2020 Q3 | 10.5 Billion EUR | 11.42% |
| 2019 Q1 | 8.65 Billion EUR | 49.48% |
| 2019 Q2 | 7.44 Billion USD | 33.09% |
| 2019 FY | 8.87 Billion EUR | 53.26% |
| 2019 Q3 | 9.2 Billion EUR | 5.29% |
| 2019 Q4 | 7.42 Billion USD | -0.39% |
| 2018 Q2 | 5.55 Billion USD | 14.08% |
| 2018 Q3 | 5.87 Billion EUR | 4.16% |
| 2018 Q1 | 5.71 Billion EUR | 13.65% |
| 2018 FY | 5.78 Billion EUR | 15.18% |
| 2018 Q4 | 5.59 Billion USD | 0.68% |
| 2017 Q4 | 4.87 Billion USD | 6.04% |
| 2017 Q1 | 4.98 Billion EUR | 18.17% |
| 2017 FY | 5.02 Billion EUR | 19.12% |
| 2017 Q2 | 4.59 Billion USD | 25.22% |
| 2017 Q3 | 5.08 Billion EUR | 3.41% |
| 2016 Q3 | 4.3 Billion EUR | 10.8% |
| 2016 Q4 | 3.67 Billion USD | -5.51% |
| 2016 Q2 | 3.88 Billion EUR | 0.0% |
| 2016 FY | 4.21 Billion EUR | 19.43% |
| 2016 Q1 | 4 Billion EUR | 13.29% |
| 2015 Q1 | 3.06 Billion EUR | 9.27% |
| 2015 Q2 | 2.97 Billion EUR | -2.81% |
| 2015 Q3 | 3.62 Billion EUR | 21.73% |
| 2015 FY | 3.53 Billion EUR | 26.15% |
| 2015 Q4 | 3.53 Billion EUR | -2.41% |
| 2014 Q1 | 2.56 Billion EUR | 15.9% |
| 2014 FY | 2.8 Billion EUR | 26.71% |
| 2014 Q4 | 2.8 Billion EUR | -3.53% |
| 2014 Q3 | 2.9 Billion EUR | 17.53% |
| 2014 Q2 | 2.47 Billion EUR | -3.58% |
| 2013 Q1 | 2.19 Billion EUR | 1.19% |
| 2013 Q3 | 2.26 Billion EUR | 6.42% |
| 2013 Q4 | 2.21 Billion EUR | -2.54% |
| 2013 FY | 2.21 Billion EUR | 1.71% |
| 2013 Q2 | 2.13 Billion EUR | -3.08% |
| 2012 Q4 | 2.17 Billion EUR | 0.0% |
| 2012 FY | 2.17 Billion EUR | 12.75% |
| 2012 Q2 | 1.97 Billion EUR | 0.0% |
| 2011 FY | 1.92 Billion EUR | 32.13% |
| 2011 Q4 | 1.92 Billion EUR | 0.0% |
| 2011 Q2 | 1.48 Billion EUR | 0.0% |
| 2010 Q4 | 1.45 Billion EUR | 0.0% |
| 2010 FY | 1.45 Billion EUR | 1.43% |
| 2010 Q2 | - EUR | 0.0% |
| 2009 Q2 | 1.05 Billion EUR | 0.0% |
| 2009 FY | 1.43 Billion EUR | 15.81% |
| 2009 Q4 | 1.43 Billion EUR | 0.0% |
| 2008 FY | 1.24 Billion EUR | 32.28% |
| 2007 FY | 938.69 Million EUR | 65.82% |
| 2006 FY | 566.09 Million EUR | 68.74% |
| 2005 FY | 335.48 Million EUR | 10.61% |
| 2004 FY | 303.31 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | 2.85 Million USD | -162273.414% |
| Arem Pacific Corporation | 224.41 Thousand USD | -2063781.079% |
| Assisted 4 Living, Inc. | 43.05 Thousand USD | -10757285.73% |
| BioCorRx Inc. | 5.63 Million USD | -82099.191% |
| Bionik Laboratories Corp. | 2.41 Million USD | -191902.766% |
| Banyan Corp. | 3.65 Million USD | -126468.754% |
| Clearday, Inc. | 45.06 Million USD | -10178.134% |
| Dental Patient Care America, Inc. | 27 Thousand USD | -17153709.118% |
| Quantum Medical Transport, Inc. | 1097.80 USD | -421907351.266% |
| Empower Clinics Inc. | 2.49 Million USD | -185763.432% |
| First Choice Healthcare Solutions, Inc. | 23.24 Million USD | -19827.8% |
| Selectis Health, Inc. | 37.24 Million USD | -12335.251% |
| Ethema Health Corporation | 14.58 Million USD | -31660.732% |
| HealthLynked Corp. | 1.97 Million USD | -234565.929% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 14.45 Million USD | -31947.63% |
| JRSIS Health Care Corporation | 1.02 Million USD | -449602.752% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 116.21 Million USD | -3885.582% |
| MedSmart Group Inc. | 788.04 Thousand USD | -587646.369% |
| North America Frac Sand, Inc. | 275 Thousand USD | -1684154.545% |
| Nova Leap Health Corp. | 208.23 Thousand USD | -2224123.128% |
| Nexteligent Holdings, Inc. | 1.88 Million USD | -246196.539% |
| PAO Group, Inc. | 639.95 Thousand USD | -723659.669% |
| Primemd Inc. | 7.13 Million USD | -64824.898% |
| Raffles Medical Group Ltd | 65.87 Million USD | -6930.931% |
| Ryman Healthcare Limited | 1.53 Billion USD | -201.635% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.34 Million USD | -343404.147% |
| Mycotopia Therapies, Inc. | 1.09 Million USD | -424572.971% |
| U.S. NeuroSurgical Holdings, Inc. | 85 Thousand USD | -5448958.824% |
| Veltex Corporation | 2.18 Million USD | -211890.506% |
| World Financial Holding Group | 98.4 Thousand USD | -4706673.03% |
| Xcelerate Inc. | 1.42 Million USD | -325894.005% |